Condition (MeSH)
Convalescence
ClinicalTrials.gov lists 19 trials for Convalescence or a narrower condition beneath it. National Institutes of Health Clinical Center (CC) has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
19 of the 19 trials are tagged with Convalescence itself; the rest are tagged with a narrower condition beneath it.
When did Convalescence trials start? (11)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2022 | 3 |
| 2021 | 1 |
| 2020 | 5 |
| 2017 | 1 |
| 2015 | 1 |
| 2013 | 1 |
| 2012 | 1 |
| 2009 | 2 |
| 2006 | 1 |
Showing 10 of 11 earlier years.
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Convalescence trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 1/2 | 1 |
| Phase 2 | 2 |
| Phase 4 | 1 |
| Not applicable | 8 |
| Observational | 5 |
How many Convalescence trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 10 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Convalescence trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institutes of Health Clinical Center (CC) | 2 |
| Biofarma | 1 |
| Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 1 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 1 |
Which drugs are being tested for Convalescence? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Nerve Growth Factor | 1 |
Interventions as named in the registry (8)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Convalesscent Plasma | 4 |
| SARS-CoV-2 non-immune Plasma | 1 |
| Ready to Use Therapeutic Food (RUTF) | 1 |
| Dynamic Chinese herbal granule formula | 1 |
| Standard Medical Care | 1 |
Showing 5 of 8 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Convalescence trials report? (2)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Grade 3 or 4 adverse events | 17 | 1 |
| Severe transfusion reaction | 1 | 1 |
Which publications cover Convalescence? (149)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Effect of Huatuo Zaizao Pill on Neurological Function and Limb Motor Recovery in Ischemic Stroke Patients During Convalescence: An Open-Labelled, Randomized Controlled Trial. | Chinese journal of integrative medicine | 2025 | Yes |
| An adaptive multiarm randomised trial of biomedical and psychosocial interventions to improve convalescence following severe acute malnutrition in sub-Saharan Africa: Co-SAM trial protocol. | BMJ open | 2025 | Yes |
| Multiple early factors anticipate post-acute COVID-19 sequelae. | Cell | 2022 | Yes |
| Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy. | Immunology | 2022 | Yes |
| Transfer Patterns of Very Low Birth Weight Infants for Convalescent Care. | Pediatrics | 2022 | Yes |
Showing 5 of 149 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.